HR Execs on the Move

NightstaRx

www.nightstarx.com

 
Nightstar is a private biopharmaceutical company focused on the development of therapies for retinal dystrophies. The Company’s lead programme is a retinal gene therapy for choroideremia, a rare inherited cause of blindness that affects around 1 in 50,000 people. Gene therapy has the potential to be an effective treatment for choroideremia and a range of other retinal dystrophies. The Company’s lead investors are Syncona LLP and NEA Inc. Syncona is an evergreen investment company, taking an active role in identifying, supporting and developing technologies with the potential to impact significantly the healthcare market of the future. NEA is a global ...
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.nightstarx.com
  • 81 Hartwell Ave Suite 100
    Lexington, MA USA 02421
  • Phone: +44 7817 868300

Executives

Name Title Contact Details

Similar Companies

Groupe Essaim

Groupe Essaim Inc. is a Boucherville, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Anuncia

Anuncia Medical, Inc., an emerging leader in Cerebrospinal Fluid (CSF) management

Clinical ink

Clinical ink is the global life science company that brings data, technology, and patient-centric research together. Our deep therapeutic-area expertise, coupled with Direct Data Capture, eCOA, eConsent, telehealth, neurocognitive testing, and digital biomarkers advancements, drive the industry standard for data precision and usher in a new generation of clinical trials. By harnessing digital data, we power sponsors, CROs, researchers, and patients to recenter decentralized trials and rewrite the clinical development experience.

Cerevance

Cerevance is advancing a promising pipeline of new treatments for central nervous system diseases.

SOLESIS

Solesis is an innovative provider of biomaterials solutions and services primarily focused on the medical device and advanced therapy industries.